London’s FTSE fell early on Friday as investors fretted over the latest set of strict Covid-19 tier designations and uncertainty over Brexit, with talks between the UK and European Union set to resume.
At 8.40 am, the FTSE 100 was off 0.94% at 6,302.98.
In corporate news, shares in AstraZeneca (AZN) softened 0.75% to £76.90 after its chief executive said the drugs giant is likely to run an additional global trial to assess the efficacy of its Covid-19 vaccine using a lower dosage following some confusion around the results of its late-stage study.
Consultancy business Capita (CPI) edged 1.2% higher to 45.4p after confirming media reports that it has entered into exclusive talks with Montagu over the potential sale of its education software solutions business.
REACH ON THE RISE
Newspaper publisher Reach (RCH) rose 8% to 166.3p on the news strong digital revenue growth has driven performance ahead of market expectations for 2020, with circulation sales also remaining resilient despite the recent lockdowns.
Immunodiagnostic Systems (IDH:AIM) shot up 37% to 274p on the news two of its Covid-19 antigen test kits are available for sale in the UK, EU and other countries which accept the CE mark as the basis of regulatory approval.
Both tests provide a result within 15 minutes and can be ‘performed by a trained healthcare professional in community locations without the need for any laboratory equipment’, said the company.
Brick manufacturer Michelmersh (MBH:AIM) was marked up 9.6% to 114p as the company said underlying revenue and profits for 2020 will exceed market expectations in spite of the challenges posed by the pandemic. The group also expects to finish 2020 in a positive net cash position and pay a final dividend of 2.25p per share.
PROFIT WARNINGS PUNISHED
Elsewhere, cloud platform LoopUp’s (LOOP:AIM) shares halved to 76.75p after it coughed up a profit warning blamed on an acceleration in churn in its non-professional services segments amid a rise in competition.
LoopUp expects performance for 2020 will be ‘moderately below current market expectations’, with revenue forecast to be no lower than £50 million and earnings before interest, tax, depreciation and amortisation (EBITDA) no lower than £15 million, representing 134% growth on 2019.
A trend of lower transaction volumes and longer conversion cycles is expected to hit revenue and earnings for the remainder of this financial year, warned Tungsten.